IL17A and psoriasis: Of great importance, the therapeutic agents currently used in the treatment of psoriasis, including retinoids, vitamin D3 analogues, dimethyl fumarate, narrow-band UVB and biologic drugs targeting subunit p19 of IL-23 and IL-17A, all have the effect of restoring the defected Tregs [6].